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Abstract— Ambient Assisted Living (AAL) aims to provide 
support to healthcare professionals making use of sensing, and 
information and communication technologies. Brain related 
information is becoming more and more relevant for many 
pathologies, but access to long-term information from brain to 
feed such AAL technologies is still giving the first steps. One 
main issue when recording signal from the brain is the available 
room for sensing device placement. Since available room is 
limited, battery-less solutions are welcome. Also, AAL solutions 
to be developed should consider not only the sensing device, but 
also the entire supporting framework. This paper introduces a 
solution for long-term monitoring of intracranial pressure using 
a wireless microdevice and a wireless sensor network. This work 
introduces a solution to achieve an enough miniaturized pressure 
sensor, powered by a wireless link, and analyzes the suitability of 
a wireless sensor network to support the data dissemination. 
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I.  INTRODUCTION 
The brain is the most complex organ in the human body. 
There are many physiological parameters that are measured in 
the human brain, and some of them are directly affected by the 
presence of tumors, aneurisms, and other disorders. 
The pressure inside the human skull is a constant parameter 
that should be maintained between certain limits (usually 5 15 
mm Hg) [1]. This pressure is called intracranial pressure (ICP) 
and is measured in the cerebrospinal fluid (CSF). An increase 
of the volume in the human cranium raises the intracranial 
pressure, which can subsequently damage human brain cells 
[2]. This condition is known as intracranial hypertension. 
Intracranial pressure increase can be caused by different 
factors, and could give us information about other underlying 
problems in the brain. For example, the appearance of brain 
tumors can cause a tissue volume raise, and therefore can 
increase the intracranial pressure. In others cases the increase 
could be related with other problems. For example, a patient 
that has acute liver failure (ALF), also has its intracranial 
pressure raised [3]. An heart failure and other blood pressure 
(BP) related problems can also raise the intracranial pressure 
[4] as indicated by the relationship between blood pressure and 
intracranial pressure, called cerebral perfusion pressure (CPP = 
BP - ICP) [1]. Intracranial hypertension could also be related 
with some diseases like meningitis. 
High values of intracranial pressure can cause brain 
damages and can be fatal if they remain high for a long time. 
ICP is also related with strokes, and can increase their 
probability of occurrence. Another disorder that can arise with 
chronically elevated intracranial pressure is Idiopathic 
intracranial hypertension (IHH). This disorder can cause a 
papilledema, which may lead to a progressive optic atrophy 
and, ultimately, blindness [5].  
Due to the described problems, continuous intracranial 
pressure monitoring is recommended, commonly to guide 
therapy and prevent irreversible damage and secondary 
neurological deterioration [2]. 
There are many ways to measure the intracranial pressure, 
which have different advantages and disadvantages [6]. The 
most common way, involves the insertion of a tiny catheter in 
the human cranium, into the brain tissue to reach the 
cerebrospinal fluid. This technique is easily done but involves 
drilling into the human skull and it only measures ICP while 
the catheter is inserted and correctly positioned. Depending on 
the catheter it can also measure the oxygen partial pressure and 
brain temperature. Other techniques bring other advantages as 
less invasiveness (doesn’t need to reach the cerebrospinal fluid) 
but with a loss in precision [6]. One recent technique involving 
a small flexible tube that is inserted into the lumbar spine 
surpasses the disadvantage of drilling into the human skull and 
can reach the cerebrospinal fluid [2]. There are other 
techniques that measure the intracranial pressure in different 
locations and with different types of sensors. However, one of 
the biggest disadvantages of these techniques is that they 
measure the ICP only during the procedure. In order to 
overcome this problem it is necessary to develop a 
microsystem that can be implanted into the brain and that can 
constantly transmit the ICP value without being necessary to 
insert a catheter again [6]. The implantation of a microsystem 
could enable a long-term measurement of the ICP while 
maintaining a good precision.  
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The arteries, as well the volumes to place the pressure 
sensor in the brain are in the millimeters range [8], making 
possible to implant microsystems if they fulfill such 
dimensions. Moreover, an intravenous (catheterization) 
approach through the brain arteries may be envisaged to 
implant the microsystem avoiding the drilling of the skull. 
Using a self-folding technique [7] it’s possible to fabricate 
microsensors and integrate them on a sub-mm microsystem, 
together with processing and communication sub-systems. 
Such dimensions make the microsystem implantation possible, 
at a moderate cost.  
Wireless implantable microsystems are expected to 
revolutionize the way we monitor a patient [9]. However, most 
of works only look at particular issues of such huge problem. 
In this paper, a broader approach is used to propose a solution 
for long-term monitoring of intracranial pressure. We propose 
a solution to fabricate the tiny implantable pressure sensor, we 
investigate the possibility to power that device using a wireless 
link, and we investigate the response of a wireless network to 
data from that sensor. 
II.  SYSTEM ARCHITECTURE 
The overall solution should guarantee the long-term 
acquisition of intracranial pressure, transmission of such data 
using a network, and make that data available for the users and 
caregivers. In order to achieve that, first the pressure must be 
recorded by the wireless implantable microdevice and sent 
outside the head. Once outside, the pressure data will be routed 
by a dedicated wireless device to a general wireless device. 
Fig. 1 shows the overall system architecture. 
 
Fig. 1. Overall system architecture for intracranial pressure acquisition. 
The pressure sensor is an implantable wireless microdevice, 
the wireless router is a device that will be placed close to the 
head and will act as an interface between the implanted 
pressure sensor and the outside world. The wireless router will 
make possible to obtain the pressure data and to wirelessly 
provide the required power to keep the pressure sensor running. 
The access devices should be any device, from smartphones to 
personal computers that will allow, and will provide access to 
the AAL system. The wireless network may be any network 
that allows the user to move freely everywhere, granting 
always the correct data delivery, with the required quality of 
service (QoS). 
A. Wireless Microdevice 
In this scenario, the most challenging sub-system is the 
wireless microdevice to measure the pressure. The device must 
be small enough (full system in the mm range [8]) to fit in the 
very small volume of interest and must provide a wireless link 
to send the measured data out, which requires the integration of 
an efficient antenna. Last but not least, pressure measurement 
in implantable devices is also a challenging issue [9, 10]. 
The solution proposed to obtain such small microdevice is 
to fabricate the device using CMOS technology, and integrate 
it with 3D antennas (fabricated using the self-folding 
technology) to allow the transmission and reception of 
radiofrequency (RF) fields. Fig. 2 shows an artistic view of the 
proposed wireless microsystem. 
 
Fig. 2. Wireless microdevice obtained by integration of an RFCMOS device 
with an add-on module based on self-folding technology. 
The CMOS technology allows to fully integrate the 
pressure sensor [11], the required RF circuitry to send data out 
and to receive the incoming RF signal that will be used to 
provide the power required for operation. The self-folding 
technology allows the integration of efficient 3D antennas. 
B. RF Link 
A fully functional pressure sensor can be operated using 
power levels from tents [12] to hundreds of microwatts [13]. 
Using more aggressive power saving solutions, it will be 
possible to reduce even further the power required for 
operation of the implantable pressure sensor. Since the full 
microsystem must be very small, it should not require a battery 
for operation to save space. In this way, it is required to use an 
energy harvesting mechanism. This paper proposal is to use an 
RF link to provide the required power for operation. 
The RF link will be used for data transmission and to power 
up the device. The data transmission link should be as efficient 
as possible but is not very challenging since the wireless router 
has some room to accommodate a very sensitive receiver to 
detect the transmitted data. However, the RF link to power up 
the device should be as efficient as possible. Using the free-
space path loss equation, it’s possible to conclude that the 
power that will reach the implanted device depends on the 
antenna efficiency (the most challenging is the antenna in the 
implanted device, which in this proposal is 3D antenna 
obtained by self-folding to maximize the efficiency), and on 
the operating frequency. Increasing the operating frequency 
will have a positive impact in the antenna efficiency but the 
tissue loss increases. Decreasing the frequency will lead to less 
losses in the tissues but the antenna efficiency will degrade. In 
this way, a correct frequency must be selected in order to 
maximize the overall link efficiency. 
Another aspect that should be taken into account is the 
standards available for wireless implantable devices and the 


	


	

	

	
	


2015 2nd International Conference on Signal Processing and Integrated Networks (SPIN)
1032
standards available for wireless data transmission over wireless 
sensor networks (WSN). Regarding the WSN, the most 
common are Bluetooth, ZigBee, and WiFi, all available for 
operation in the 2.4 GHz band. Regarding the implanted 
devices, we have the Medical Implant Communication Service 
(MICS), a standard that uses RF carriers in the 400 MHz 
region, a frequency that will not suffer severe loss due to 
interaction with human tissues. However, since it requires large 
antennas, more recently the IEEE 802.15.6 [14, 15], also 
known as Medical Body Area Network (MBAN) was made 
available, allowing the use of a band close to the 2.4 GHz.  
Considering that the preferred frequencies to transmit 
power into dispersive tissues are in the 1-10 GHz range [16], 
the desired dimension for the implanted device (sub-mm), and 
the standard frequencies used in implanted devices, it was 
decided to implement an RF link in the 2-3 GHz range. Section 
on tests will show the measured attenuation for such a link. 
C.  Supporting Wireless Network 
The main requirement for the wireless network in Fig. 1 is 
its ability to provide the required QoS. When considering 
biomedical applications, mostly, the QoS will be defined in 
terms of data delay (time from data acquisition to data deliver), 
and in terms of error rate (it may be bit error rate or packet 
reception rate - PRR). In same situations, the network 
persistence may also be an issue, however it may be 
disregarded once the data delay is guaranteed. 
Sensor networks have been widely used in biomedical 
applications to transport highly demanding biosignals, as the 
electrocardiogram (ECG) or the electroencephalogram (EEG), 
where the data rate required is in the order of hundreds of 
kilobits per second per channel. The next section on tests will 
present data measured on a real scenario showing the 
possibility to run a wireless network with stable QoS for 
biomedical applications. 
Depending on the pathology to be monitored, the required 
pressure data rate may change, but will be allays less 
demanding then ECG or EEG signals. The worst scenario 
would be to monitor the blood pressure at each hearth beat. 
However, it would be less demanding then the need to record 
the ECG waveform, or multiple EEG waveforms. 
D. Access Devices 
After being able to get the pressure signal outside the 
human head, it will be made available to different type of users 
through the wireless router and the wireless network. To assure 
data availability to the users of interest (the person being 
monitored and/or caregivers), an information and 
communication technology platform must ensure proper data 
access to different levels of permissions. Besides the 
framework to support all the interactions, it must work based 
on standard devices that everybody may have access, like 
smartphones or tablets.  
To support the monitoring of different biosignals, we 
developed and tested a framework to allow the remote access 
and management of such signals [17]. The proposed solution 
was tested to display real time signals like ECG, based on 
medium range smartphones running the open source operating 
system Android. 
III. TESTS AND DISCUSSION 
The implementation of the proposed system faces two 
critical issues. One is the possibility to power-up the device 
using an RF link. The other is the possibility to send the data 
through a wireless network, being able to reach the destination 
for data processing and user feedback. 
A. Wireless Powering 
To test the attenuation expected by the RF link proposed by 
the technology of Fig. 2, the setup of Fig. 3 was used: 
 
Fig. 3. Setup used to test the wireless link attenuation. 
Fig. 3 shows the Q-Par wideband horn antenna used to feed 
the system, and the 3D receiving antenna immersed in a 
deionized water solution to mimic the presence of human tissue 
(5 cm around the antenna). The antennas were placed 10 cm (5 
cm solution plus 5 cm air) apart and a vector network analyser 
(E8357A PNA – 300 kHz to 9 GHz) was used to measure the 
S21, giving an idea of path loss at different frequencies. Fig. 4 
shows the measured results obtained. 
 
Fig. 4. Path loss of the RF link between an horn antenna and the 3D 
implanted antenna, considering 5 cm of solution and 5 cm of air. 
From the previous figure, it’s possible to observe that the 
path loss, despite being high, will make possible to feed the 
implanted device with powers in the range of tens of 
microwatts. 
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B. Network QoS 
To understand if it would be possible to deploy the 
proposed monitoring solution, a wireless sensor network (based 
on IEEE 802.15.4) was deployed in a real hospital 
environment. Fig. 5 shows the deployment scenario. 
 
Fig. 5. Deployment scenario for a wireless sensor network to support the 
implantable pressure sensor in real hospital environment. 
In this scenario we have three nodes in one room sending 
data trough the wireless network. Each node was programmed 
to send packets of 70 bytes each 500 ms. To test network 
suitability, the QoS parameters used was the PRR. SN2 was 
used as a test node that would represent the implanted pressure 
traffic. To see the impact on the network, that node was turned 
ON and OFF, and we measured the PRR, as shown in Fig. 6. 
 
Fig. 6. Wireless network testing using PRR (Packet Reception Ratio) as the 
QoS measure to access the network quality. 
Fig. 6 shows a severe degradation when severe interference 
was present. In this case several people were interfering with 
the propagating path.In what respect to the sole effect of data 
transmission, it can be observed the effect that turning ON 
(3000 s) and OFF (9500 s) the implanted sensor would have. It 
can be observed a degradation of the PRR, however this was a 
scenario were the data rate was selected to be very heavy for 
the network (each node send 70 bytes each 500 ms). Even in 
this adverse scenario, with this experience, and others, we were 
able to conclude that such network would allow the 
implementation of the desired real-time monitoring of 
intracranial pressure using this standard network technology. 
IV. CONCLUSIONS AND FUTURE WORK 
This work proposes a closed loop solution to supervise the 
intracranial pressure. The critical issues under analysis were 
device dimension, RF link for power and data transmission, 
and wireless network suitability for data transmission and 
automatic feedback to the user or to the caregivers. To obtain 
the desired device dimensions, a combination of RFCMOS 
standard technology with 3D fabrication technology was 
proposed and the required antenna was fabricated. The RF link 
was selected, implemented, and measured. It was verified that 
the resulting attenuation in the frequency range 2-3 GHz will 
allow to power the microdevice with a wireless link. Finally, a 
wireless network was deployed in a real hospital environment 
to assess the possibility of using a standard WSN as a support 
for the pressure monitoring system. It was verified that, even 
with adverse conditions, the network was able to deliver the 
required data. This paper shows how to combine a set of 
technologies to implement and deploy a system to allow long-
term monitoring of intracranial pressure. 
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